SCHEMBL8669816

SCHEMBL8669816

COCCCOc1ccnc(-c2nc3ccccc3n2[S+](C)[O-])c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AR P10275 3/20 0.38
▸ HPGD P15428 2/20 0.38
▸ KDM4E B2RXH2 3/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ TP53 P04637 5/20 0.37
▸ LMNA P02545 2/20 0.37
▸ HTT P42858 2/20 0.37
▸ TSHR P16473 4/20 0.37
▸ PDE2A O00408 1/20 0.37
▸ MAPT P10636 2/20 0.37
▸ NPSR1 Q6W5P4 2/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ RAB9A P51151 3/20 0.36
▸ NPC1 O15118 2/20 0.36
▸ CTSD P07339 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8503831 0.98 MAPT (0.39) ARHPGDKDM4EALDH1A1SMN1; SMN2
SCHEMBL8669096 0.81 AR (0.41) ARHPGDKDM4EALDH1A1SMN1; SMN2
SCHEMBL8439253 0.79 MAPT (0.41) HPGDKDM4EALDH1A1SMN1; SMN2TP53
SCHEMBL8668975 0.78 AR (0.41) ARHPGDKDM4EALDH1A1SMN1; SMN2
SCHEMBL8633727 0.78 MAPT (0.41) HPGDKDM4EALDH1A1SMN1; SMN2TP53
SCHEMBL637824 0.75 KDM4E (0.47) HPGDKDM4EALDH1A1HTTTSHR
SCHEMBL8672637 0.73 SMN1; SMN2 (0.37) HPGDKDM4EALDH1A1SMN1; SMN2TP53
SCHEMBL8670481 0.72 ALDH1A1 (0.36) HPGDKDM4EALDH1A1SMN1; SMN2LMNA
SCHEMBL8504531 0.70 CCR1 (0.31) CTSD
SCHEMBL8670475 0.70 HPGD (0.34) HPGDKDM4EALDH1A1SMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5840910-A Pyridine derivatives having anti-ulcerative activity ESAI CO., LTD. (JP) 1998-11-24 — — US disclosed
EP-0268956-A2 Pyridine derivatives, pharmaceutical compositions comprising the same, the use of the same for the manufacture of medicaments having therapeutic or preventative value, and a process for preparing the same Eisai Co., Ltd. (JP) 1988-06-01 — — EP disclosed
Send feedback